Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
日曜日, 8 23

Hims & Hers Health Inc

HIMSNYSE
Trade with Public
Trade with Public
$33.78
1.926.03%
近くで: Aug 21, 5:00 PM EST
$33.73
-0.055-0.16%
時間外: Aug 21, 7:53 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Hims & Hers Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Hims & Hers Health (HIMS).

Price Target Range — 10 Quarters

Analyst Consensus — 14 Analysts

4Buy
10Hold
Consensus RatingHold# Analysts14Avg. Consensus PT$31Upside to Avg. PT-8.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 21, 2026BarclaysGlen SantangeloPT CutOverweight$39→$35
Aug 11, 2026CitigroupDaniel GrosslightPT CutNeutral$35→$33
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Overweight on Hims & Hers Health, Lowers Price Target to $35

Barclays analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Overweight and lowers the price target from $39 to $35.
Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Hims & Hers Health, Lowers Price Target to $33

Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and lowers the price target from $35 to $33.
Benzinga Newsdesk

PRO
Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $26.
Benzinga Newsdesk

PRO
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $32

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $30 to $32.
Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30

TD Cowen analyst Jonna Kim maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $30.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Raises Price Target to $28

Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and raises the price target from $21 to $28.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved